Envoy Medical, Inc.
- Market Cap (Float-Adj) (Float-adjusted market cap computed by the low-float screener — matches the screener row. May differ from the standard cap (price × all shares outstanding) reported elsewhere.)
- $50.6M
- Price
- $0.6534
- % Change (Daily % change from the live per-ticker quote feed.)
- +0.34%
- Volume
- 76.5K
About
Envoy Medical, Inc. is a healthcare company dedicated to developing innovative medical technologies that address the full spectrum of hearing loss. Its diverse product portfolio includes conventional hearing aids, Esteem middle ear implants, bone conduction devices, and Acclaim cochlear implants. Established in 1995, the company originally operated as St. Croix Medical, Inc. before officially rebranding to Envoy Medical, Inc. in December 2004. Envoy Medical, Inc. is headquartered in White Bear Lake, Minnesota.
Quick stats
Shares outstanding77.4M
Computed float46.3M
Float / shares59.8%
Cash runway (months)6.9
Key info
SectorHealthcare
IndustryMedical - Devices
CIK (Central Index Key — the unique ID the SEC assigns to every filer. Use it to look up the company's filings on EDGAR.)0001840877
Websitehttps://www.envoymedical.com
AI Summary
AI-generated1/37
minorneutralother
Envoy Medical Announces New Patents, Further Expanding Global Patent Portfolio
Envoy Medical announced the grant of two new international patents — one from Canada and one from Hong Kong — bringing its global portfolio to 97 granted patents (40 U.S., 57 foreign) with 35 pending applications.
The Canadian patent covers lead characterization in implantable cochlear systems; the Hong Kong patent covers compensation for middle-ear sensor variability, both supporting the company's fully implanted hearing platform.
The IP news is incremental and does not change the regulatory timeline for the investigational Acclaim cochlear implant, which remains under a U.S. pivotal clinical trial with FDA Breakthrough Device Designation.